CSL reported $11.96B in Debt for its fiscal semester ending in December of 2024.





Debt Change Date
Alterity Therapeutics Limited AUD 210.39K 120.67K Jun/2023
Arca Biopharma USD 0 0 Mar/2025
aTyr Pharma USD 1.81M 29K Mar/2026
Bio Path USD 261K 261K Mar/2025
Brainstorm Cell Therapeutics USD 1.2M 1.2M Mar/2025
Cara Therapeutics USD 0 0 Mar/2025
CSL USD 11.96B 219M Dec/2024
Curis USD 0 0 Jun/2022
Immunic USD 0 0 Jun/2024
Minerva Neurosciences USD 0 0 Sep/2024
Sangamo BioSciences USD 0 0 Jun/2022
TherapeuticsMD USD 93.6M 2.82M Sep/2022